Professor of Surgery, Brigham and Women's Hospital
Urology
Dr. Adam S. Kibel, MD
|
|
Give Review
Doctor Adam S. Kibel, MD practices Urology. He researched medicine at Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University has a rank of 18 in research and a 49 in primary care He over the years received 3 awards: "America's Top Doctors for Cancer", "America's Top Doctors" and "Boston Magazine". Adam Kibel is also published. He has 96 publications published. The lastest publication: "Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer.' Adam S. Kibel is registered with Medicare and accepts Medicare payments.
Publications
- Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate Cancer.
- The Contemporary Incidence and Sequelae of Rhabdomyolysis Following Extirpative Renal Surgery: A Population Based Analysis.
- Medical androgen deprivation therapy and increased non-Cancer mortality in non-metastatic prostate Cancer patients aged â¥66 years.
- Genome-Wide Association Study of Prostate Cancer-Specific Survival.
- The effects of height and BMI on prostate Cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consor...
- Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
- Urolithiasis and Urinary Tract Infection Among Patients With Inflammatory Bowel Disease: A Review of US Emergency Department Visits between 2006 and 2009.
- Effect of Preoperative Angina Pectoris on Cardiac Outcomes in Patients With Previous Myocardial Infarction Undergoing Major Noncardiac Surgery (Data from ACS-NSQIP).
- The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update.
- Re: enzalutamide in metastatic prostate Cancer before chemotherapy.
- Readmissions after major urologic Cancer surgery.
- Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
- Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
- Are Biochemical Recurrence Outcomes Similar After Radical Prostatectomy and Radiation Therapy? Analysis of Prostate Cancer-Specific Mortality by Nomogram-predicted Ris...
- Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer.
- Castration-Resistant Prostate Cancer: AUA Guideline Amendment.
- A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate Cancer.
- Contemporary Nationwide Patterns of Self-reported Prostate-Specific Antigen Screening.
- Transperineal In-Bore 3-T MR Imaging-guided Prostate Biopsy: A Prospective Clinical Observational Study.
- Effect of Minimally Invasive Surgery on the Risk for Surgical Site Infections: Results From the National Surgical Quality Improvement Program (NSQIP) Database.
- Chronic kidney disease and perioperative outcomes in urological oncological surgery.
- Generalizability of established prostate Cancer risk variants in men of African ancestry.
- Preventable Mortality Following Common Urologic Surgery: Failing to Rescue?
- Clinical-pathologic stage discrepancy in Bladder cancer patients treated with radical cystectomy: results from the national cancer data base.
- Local treatment of high risk prostate Cancer: Role of surgery and radiation therapy.
- Morbidity and Mortality After Benign Prostatic Hyperplasia Surgery: Data from the American College of Surgeons National Surgical Quality Improvement Program.
- Reply to Michael Froehner's Letter to the Editor re: Kenneth G. Nepple, Andrew J. Stephenson, Dorina Kallogjeri, et al. Mortality After Prostate Cancer Treatment with ...
- Propensity-Matched Comparison of Morbidity and Costs of Open and Robot-Assisted Radical Cystectomies: A Contemporary Population-Based Analysis in the United States.
- Prostate Cancer (PCa) Risk Variants and Risk of Fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
- Early Detection, PSA Screening, and Management of Overdiagnosis.
- The health care burden of skeletal-related events in Renal cell carcinoma patients with bone metastases.
- Predicting Risk of Bladder Cancer Using Clinical and Demographic Information from Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Participants.
- Cytoreductive nephrectomy in patients with metastatic non-clear cell Renal cell carcinoma.
- Constitutive β-catenin Activation Induces Male-Specific Tumorigenesis in the Bladder Urothelium.
- Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate Cancer after radical prostatectomy (TAX-3501): Important lessons for future trials.
- Re: Intermittent Androgen Suppression for Rising PSA Level After Radiotherapy.
- Castration-Resistant Prostate Cancer: AUA Guideline.
- Randomized controlled trial of oxybutynin extended release versus placebo for Urinary symptoms during intravesical bacillus calmette-guérin treatment.
- Global patterns of prostate Cancer incidence, aggressiveness, and mortality in men of african descent.
- 11C-Acetate PET/CT Before Radical Prostatectomy: Nodal Staging and Treatment Failure Prediction.
- Mortality After Prostate Cancer Treatment with Radical Prostatectomy, External-Beam Radiation Therapy, or Brachytherapy in Men Without Comorbidity.
- Reply from Authors re: Manfred P. Wirth, Johannes Huber. What Really Matters Is Rarely Measured: Outcome of Routine Care and Patient-reported Outcomes. Eur Urol. In pr...
- The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) Initiative: Rationale and Design.
- Contemporary role of systematic Prostate biopsies: indications, techniques, and implications for patient care.
- Who should be included in a clinical trial of screening for Bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screeni...
- Complications After Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
- Urologic Clinics of North America. Castrate-resistant prostate Cancer. Preface.
- Foamy gland adenocarcinoma of the Prostate: incidence, Gleason grade, and early clinical outcome.
- Treat Now or Later: The Dilemma of Postoperative Radiotherapy.
- Targeting the androgen receptor--theory and practice.
- Indications and practice with androgen deprivation therapy.
- Highlights of the 2010 SUO Annual Meeting.
- Laparoscopic Retroperitoneal Lymph Node Dissection for Low-Stage Cancer: A Washington University Update.
- Prediction of erectile function following treatment for prostate Cancer.
- Early oncologic outcomes of robotic vs. open radical cystectomy for urothelial Cancer.
- Genome-wide association study of prostate Cancer in men of African ancestry identifies a susceptibility locus at 17q21.
- Editorial for "Prediction of significant prostate Cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50".
- Positive Margin During Partial Nephrectomy: Does Cancer Remain in the Renal Remnant?
- Prostate Cancer predisposition loci and risk of metastatic disease and prostate Cancer recurrence.
- Ability of Linear Length of Positive Margin in Radical Prostatectomy Specimens to Predict Biochemical Recurrence.
- Validation of genome-wide prostate Cancer associations in men of African descent.
- Counterpoint: Prostate carcinoma treatment for the young patient--The case for radical Prostatectomy.
- The Gleason score of tumor at the margin in radical Prostatectomy is predictive of biochemical recurrence.
- Association of CASP8 D302H polymorphism with reduced risk of aggressive Prostate carcinoma.
- High-risk localized prostate Cancer: role of radical prostatectomy.
- BCAN Think Tank session 3: Prevention of Bladder cancer.
- Percent microscopic tumor necrosis and survival after curative surgery for Renal cell carcinoma.
- Risk of urinary incontinence following Prostatectomy: the role of physical activity and obesity.
- Effect of reclassification on the incidence of benign and malignant Renal tumors.
- The role of lymphovascular space invasion in Renal cell carcinoma as a prognostic marker of survival after curative resection.
- Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive Bladder carcinoma.
- Intravesical bacille Calmette-Guérin therapy for non-muscle-invasive Bladder cancer: effects of concurrent statin therapy.
- Prostate Cancer risk associated loci in African Americans.
- Highlights of the 2008 SUO/SBUR annual meeting: current controversies in urologic oncology.
- Magnetic resonance diffusion characteristics of histologically defined prostate Cancer in humans.
- Variation in KLK genes, prostate-specific antigen and risk of prostate Cancer.
- Percentage of high-grade carcinoma as a prognostic indicator in patients with Renal cell carcinoma.
- Impact of comorbidity on overall survival in patients surgically treated for Renal cell carcinoma.
- Association between polymorphisms in cell cycle genes and advanced Prostate carcinoma.
- The distribution of histological subtypes of Renal tumors by decade of life using the 2004 WHO classification.
- Prostate Cancer: screening, diagnosis and management in 2007.
- The use and abuse of data: nomograms and talking to patients about clinical medicine.
- Optimizing Prostate biopsy techniques.
- Prostate-specific antigen density predicts adverse pathology and increased risk of biochemical failure.
- Adjuvant weekly docetaxel for patients with high risk prostate Cancer after radical prostatectomy: a multi-institutional pilot study.
- Trends in nephron-sparing surgery for Renal neoplasia.
- Minimally invasive approaches to localized Prostate carcinoma.
- Single nucleotide polymorphisms: early diagnosis and risk assessment in genitoUrinary malignancy.
- Association of hereditary prostate Cancer gene polymorphic variants with sporadic aggressive prostate carcinoma.
- An interdisciplinary approach to treating prostate Cancer.
- Expression mapping at 12p12-13 in advanced Prostate carcinoma.
- Transitional cell carcinoma of the renal pelvis associated with hypercalcemia in a patient with autosomal dominant polycystic Kidney disease.
- Surgical treatment of Renal neoplasia: evolving toward a laparoscopic standard of care.
- Xq27-28 deletions in Prostate carcinoma.
- CDKN1A and CDKN1B polymorphisms and risk of advanced Prostate carcinoma.
Schools
Weill Cornell Medical College
Brigham and Women39s Hospital
Procedures Preformed
- AdRenalectomy
- Cystectomy
- Cystometry
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Blood in Urine (Hematuria)
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- America's Top Doctors for Cancer
- America's Top Doctors
- Boston Magazine
Education
-
Brigham and Women's Hospital -
Weill Cornell Medical College of Cornell University
Hospital
-
Brigham and Women's Faulkner Hospital -
Brigham and Women's Hospital -
Dana-Farber Cancer Institute
Drug Facts
| NPI NUMBER | 1285650580 | |
| NPPES Provider LastName | KIBEL | |
| NPPES Provider FirstName | ADAM | |
| NPPES Provider ZIPCode | 021156105 | |
| NPPES Provider State | MA | |
| Specialty Description | Urology | |
| Total Claim Count | 39.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1285650580 |
| Last Name Of The Provider | KIBEL |
| First Name Of The Provider | ADAM |
| View All |
Similar Doctors
|
|
Dr. Prasanta K. Mitra, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William W. Bassett III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dayron Rodriguez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward M. Gong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard N. Yu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian H. Eisner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Niall M. Heney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rafael D. Fernandex, MD |